Vascular stiffness in familial hypercholesterolaemia is associated with C-reactive protein and cholesterol burden

European Journal of Clinical Investigation

Volumn 37, Issue 3, 2007, Pages 197-206

  Cheng, H M ^a,c   Ye, Z X ^a   Chiou, K R ^b,c   Lin, S J ^a,c   Charng, M J ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Arterial stiffness; Atherosclerosis; Familial hypercholesterolaemia; Intima medial thickness; Pulse wave velocity

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERY DIAMETER; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; INTIMA; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; PULSE WAVE; RISK FACTOR; STATISTICAL ANALYSIS; TUNICA MEDIA;

ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ELASTICITY; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PEDIGREE; RISK FACTORS; TUNICA INTIMA; VASCULAR RESISTANCE;

EID: 33847230607     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01772.x     Document Type: Article

References (35)

1. Descamps OS, Gilbeau JP, Leysen X, Van Leuven F, Heller FR. Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia. Eur J Clin Invest 2001;31:958-65.
2. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004;160:407-20.
3. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
4. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001;103:987-92.
5. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002;39:10-5.
6. Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y et al. Pulse wave velocity as an indicator of atherosclerosis in impaired fasting glucose: the Tanno and Sobetsu study. Diabetes Care 2003;26:437- 40.
7. Munakata M, Ito N, Nunokawa T, Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003;16:653-7.
8. Chang KC, Tseng CD, Chou TF, Cho YL, Chi TC, Su MJ et al. Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes. Eur J Clin Invest 2006;36:1-7.
9. Lin YP, Chen CH, Hsu TL, Yang WC, Ding YA. Sequential tonometry as a practical method to estimate truncal pulse wave velocity. J Chin Med Assoc 2001;64:693-702.
10. Cheng HM, Yu WC, Chen CH. Prevalence of arteriosclerosis and atherosclerosis in stable patients at a cardiovascular outpatient clinic: potential for better care. J Chin Med Assoc 2006;69:14-20.
11. Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001;104:63-7.
12. Cushman M, Arnold AM, Psaty BM, Manolio TA, Kuller LH, Burke GL et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005;112:25-31.
13. Ueland T, Vissers MN, Wiegman A, Rodenburg J, Hutten B, Gullestad L et al. Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Invest 2006;36:147-52.
14. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
15. Tomiyama H, Arai T, Koji Y, Yambe M, Hirayama Y, Yamamoto Y et al. The relationship between high-sensitive C-reactive protein and pulse wave velocity in healthy Japanese men. Atherosclerosis 2004;174:373-7.
16. Yasmin McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004;24:969-74.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
18. Schmidt HH, Hill S, Makariou EV, Feuerstein IM, Dugi KA, Hoeg JM. Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 1996;77:575-80.
19. Hoeg JM, Feuerstein IM, Tucker EE. Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb 1994;14:1066-74.
20. Et-Taouil K, Safar M, Plante GE. Mechanisms and consequences of large artery rigidity. Can J Physiol Pharmacol 2003;81:205-11.
21. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002;25:359-64.
22. Cheung YF, Ho MH, Tam SC, Yung TC. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 2004;90:1281-5.
23. Arroyo-Espliguero R, Mollichelli N, Avanzas P, Zouridakis E, Newey VR, Nassiri DK et al. Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X. Eur Heart J 2003;24:2006-11.
24. Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z et al. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 2005;45:997-1003.
25. Wong M, Toh L, Wilson A, Rowley K, Karschimkus C, Prior D et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 2003;48:81-9.
26. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H, Pannier B. Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int 2003; 63 (Suppl.):S88-93.
27. Pirro M, Schillaci G, Savarese G, Gemelli F, Vaudo G, Siepi D et al. Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia. Eur J Clin Invest 2004;34:335-41.
28. Stefanadis C, Stratos C, Boudoulas H, Kourouklis C, Toutouzas P. Distensibility of the ascending aorta. Comparison of invasive and non-invasive techniques in healthy men and in men with coronary artery disease. Eur Heart J 1990;11:990-6.
29. Amar J, Ruidavets JB, Sollier CB, Bongard V, Boccalon H, Chamontin B et al. Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness. J Hypertens 2004;22:349-55.
30. Pitsavos C, Toutouzas K, Dernellis J, Skoumas J, Skoumbourdis E, Stefanadis C et al. Aortic stiffness in young patients with heterozygous familial hypercholesterolemia. Am Heart J 1998;135:604-8.
31. Smilde TJ, van den Berkmortel FW, Wollersheim H, van Langen H, Kastelein JJ, Stalenhoef AF. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia. Eur J Clin Invest 2000;30:473-80.
32. Dart AM, Gatzka CD, Cameron JD, Kingwell BA, Liang YL, Berry KL et al. Large artery stiffness is not related to plasma cholesterol in older subjects with hypertension. Arterioscler Thromb Vasc Biol 2004;24:962-8.
33. McDonald DA. Regional pulse-wave velocity in the arterial tree. J Appl Physiol 1968;24:73-8.
34. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006;354:1264-72.
35. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439-41.